Any stock, in context
NECLIFE · Healthcare
Nectar Lifesciences Limited
Observation · 15 Oct 2026
How these are readNectar Lifesciences closed at ₹10.04 on 15 Oct 2026, 18.7% below its 200-day average and 9.5% below its 50-day average: below both lines. It sits 54.9% below its highest close of the past year, in the bottom fifth of its one-year range. Over three months it fell 7.5%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- Thinly traded: under ₹1 crore a day
- vs 200-day
- −18.7%
- the long line
- vs 50-day
- −9.5%
- the short line
- From 52w high
- −54.9%
- ₹9.300₹22.40
- 3 months
- −7.5%
- sector median −2.7% · 92 of 146
Listed outside the Nifty indices · Healthcare (sector mapped from its industry) · EQ series · median traded value ₹0.14 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- −1.18%
- 1W
- –
- 1M
- −11.93%
- 3M
- −7.46%
- YTD
- –
- 1Y
- −25.57%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.